Immutep Limited (IMM.AX)
AUD 0.35
(-4.17%)
AUD 0.35
(-4.17%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 | 1.22 Million AUD | -29.16% |
| 2021 | 1.73 Million AUD | -38.41% |
| 2020 | 2.81 Million AUD | -68.9% |
| 2019 | 9.05 Million AUD | 18.43% |
| 2018 | 7.64 Million AUD | 15.0% |
| 2017 | 6.64 Million AUD | 15.0% |
| 2016 | 5.77 Million AUD | 14.96% |
| 2015 | 5.02 Million AUD | 233.26% |
| 2014 | 1.5 Million AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | -100.0% |
| 2009 | 700 Thousand AUD | 191.2% |
| 2008 | 240.38 Thousand AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 Q2 | 952.65 Thousand AUD | 0.0% |
| 2022 Q4 | 1.22 Million AUD | 0.0% |
| 2022 FY | 1.22 Million AUD | -29.16% |
| 2021 Q4 | 1.73 Million AUD | 0.0% |
| 2021 FY | 1.73 Million AUD | -38.41% |
| 2021 Q2 | 3.03 Million AUD | 0.0% |
| 2020 Q4 | 2.81 Million AUD | 0.0% |
| 2020 Q2 | 9.75 Million AUD | 0.0% |
| 2020 FY | 2.81 Million AUD | -68.9% |
| 2019 Q2 | 8.48 Million AUD | 0.0% |
| 2019 Q4 | 9.05 Million AUD | 0.0% |
| 2019 FY | 9.05 Million AUD | 18.43% |
| 2018 Q2 | 7.14 Million AUD | 0.0% |
| 2018 Q4 | 7.64 Million AUD | 0.0% |
| 2018 FY | 7.64 Million AUD | 15.0% |
| 2017 Q2 | 6.21 Million AUD | 0.0% |
| 2017 FY | 6.64 Million AUD | 15.0% |
| 2017 Q4 | 6.64 Million AUD | 0.0% |
| 2016 Q2 | 5.4 Million AUD | 0.0% |
| 2016 Q3 | 5.58 Million AUD | 3.48% |
| 2016 FY | 5.77 Million AUD | 14.96% |
| 2016 Q4 | 5.77 Million AUD | 3.4% |
| 2015 Q2 | 4.69 Million AUD | 0.0% |
| 2015 Q4 | 5.02 Million AUD | 0.0% |
| 2015 FY | 5.02 Million AUD | 233.26% |
| 2014 Q2 | 667.08 Thousand AUD | 0.0% |
| 2014 Q4 | 1.5 Million AUD | 0.0% |
| 2014 FY | 1.5 Million AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2012 Q2 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | -100.0% |
| 2009 FY | 700 Thousand AUD | 191.2% |
| 2008 FY | 240.38 Thousand AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 123.85 Thousand AUD | -891.69% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 5.65 Million AUD | 78.274% |
| Biome Australia Limited | 1.3 Million AUD | 5.932% |
| Patrys Limited | - AUD | -Infinity% |
| Orthocell Limited | 689.69 Thousand AUD | -78.089% |
| Imugene Limited | 1.54 Million AUD | 20.599% |
| Noxopharm Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | 1.11 Million AUD | -10.377% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | 330.48 Thousand AUD | -271.655% |
| Proteomics International Laboratories Limited | 316.39 Thousand AUD | -288.207% |
| Cynata Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 18.24 Billion AUD | 99.993% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 879.78 Thousand AUD | -39.61% |
| Starpharma Holdings Limited | 3.52 Million AUD | 65.185% |
| Nanollose Limited | 42.53 Thousand AUD | -2788.004% |
| Memphasys Limited | 4.41 Million AUD | 72.168% |
| Invex Therapeutics Ltd | - AUD | -Infinity% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 1.56 Million AUD | 21.352% |
| Botanix Pharmaceuticals Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 421.96 Thousand AUD | -191.081% |
| Race Oncology Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 17.44 Million AUD | 92.959% |
| Dimerix Limited | 149.68 Thousand AUD | -720.579% |
| PharmAust Limited | - AUD | -Infinity% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 159.04 Thousand AUD | -672.277% |
| BTC Health Limited | - AUD | -Infinity% |
| Acrux Limited | 1.48 Million AUD | 17.4% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Biotron Limited | 7130.00 AUD | -17126.76% |
| Tissue Repair Ltd | - AUD | -Infinity% |
| AdAlta Limited | 2.49 Million AUD | 50.762% |
| Radiopharm Theranostics Limited | - AUD | -Infinity% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 23.59 Thousand AUD | -5106.29% |
| Paradigm Biopharmaceuticals Limited | 239.33 Thousand AUD | -413.211% |
| Recce Pharmaceuticals Ltd | 811.19 Thousand AUD | -51.416% |
| Avecho Biotechnology Limited | 175.15 Thousand AUD | -601.262% |
| Actinogen Medical Limited | 319.06 Thousand AUD | -284.954% |
| Immuron Limited | 173.49 Thousand AUD | -607.948% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |